Latest news

Nick is taking part in the Great North Run for the third time in September and this year his daughter Amie will be joining him on Team MS Trust for her first half marathon. Here, Nick and Amie tell us about the inspiration behind their fundraising.

The European Medicines Agency has recommended a temporary restriction on people who should start treatment with Lemtrada while a review of side effects is carried out. 

From 1 April 2019, gabapentin and pregabalin have been reclassified as controlled drugs, which affects how they can be prescribed.

• Mavenclad (cladribine) approved in USA
• Gabapentin and pregabalin reclassified
• Do dietary levels of minerals affect risk of getting MS?

Fee was diagnosed with MS over 10 years ago. Here she tells us how her daily strength, balance and stretch exercises help with her MS symptoms. 

• Drug for relapsing and SPMS approved in USA
• Cells age quicker in PPMS
• Finances and change of retirement age
• New neurology standards in Scotland

Our brilliant supporter Vikki will be shaving her head to raise vital funds for the MS Trust. Here she tells us about the inspiration behind her fundraising.

We are thrilled to report on a number of benefits for people with MS thanks to the MS Trust's Specialist Nurse Programme. 

Jennie Harrod writes about her journey with MS and how swimming has helped her, both mentally and physically.

• Time to disability build up getting longer
• Long term effects of beta interferon
• Reduced sweating may be linked to fatigue
• Weight at puberty linked to MS risk
• Access to medicinal cannabis

How your children will cope with your MS, is an ongoing concern for the majority of parents following diagnosis. Here Martin Baum, who was diagnosed with MS over 20 years ago and his son Josh, discuss how they coped and the impact it has had on them over the years.

This research explores how couples and families affected by MS seek, share and withhold health information.